FDA Inspection 1078696 — Barbara Ann Karmanos Cancer Hospital

Barbara Ann Karmanos Cancer Hospital — FEI 3009027673

The FDA completed an inspection of Barbara Ann Karmanos Cancer Hospital on February 4, 2019 in Detroit, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 4, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Detroit, MI (United States)

Citations

IDCFRDescription
1776421 CFR 212.20(e)Written QA procedures established, followed
1784921 CFR 212.60(a)Testing procedures